Figures & data
Figure 1. Thermotherapy treatment of the pelvic region after intratumoral injection of magnetic nanoparticles using the alternating magnetic field applicator MFH 300F® (MagForce Nanotechnologies AG, Berlin, Germany).
![Figure 1. Thermotherapy treatment of the pelvic region after intratumoral injection of magnetic nanoparticles using the alternating magnetic field applicator MFH 300F® (MagForce Nanotechnologies AG, Berlin, Germany).](/cms/asset/93cf9745-925f-487e-ad01-65ebca5c9b08/ihyt_a_310641_f0001_b.gif)
Figure 2. Postoperative CT scan of a glioblastoma patient showing magnetic nanoparticles deposits as hyperdense areas within the tumor tissue (left hand). Isothermal lines indicate calculated intratumoral temperatures for a magnetic field strength of 8.0 kA/m corresponding to an SAR of 718 W/kg (derived from the Hounsfield units in the CT scan). The brown line (right hand) represents the tumor area identified by preoperative MRI as fused with the CT scan.
![Figure 2. Postoperative CT scan of a glioblastoma patient showing magnetic nanoparticles deposits as hyperdense areas within the tumor tissue (left hand). Isothermal lines indicate calculated intratumoral temperatures for a magnetic field strength of 8.0 kA/m corresponding to an SAR of 718 W/kg (derived from the Hounsfield units in the CT scan). The brown line (right hand) represents the tumor area identified by preoperative MRI as fused with the CT scan.](/cms/asset/8c65e033-a94b-471d-8531-d1c65571a14a/ihyt_a_310641_f0002_b.gif)